Thorne Research Inc. and Itamar Medical Inc. entered into a three-year non-exclusive agreement to co-market Itamar's EndoPAT and WatchPat. EndoPat is a device to assess arterial (endothelial) function, and WatchPAT is a home-based sleep test to diagnose obstructive sleep apnea. The U.S. Food and Drug Administration (FDA) have cleared both.

CVIS, cardiovascular information system

The push for healthcare to be digitally transformed and paper-free means having access to electronic medical records anytime/anywhere. This effort amplified, has left many cardiology departments struggling to catch up.  According to the Administration on Aging people 65+ represented 12.4 percent of the population in the year 2000, but are expected to grow to be 19 percent of the population by 2030. The increase in longevity-on top of advances in medications, less invasive treatments and diagnostic testing will greatly increase demand for cardiology.  
Blackford Analysis, a provider of software products that accelerate comparison of medical images, introduced its products to the Middle Eastern market at the Arab Health Congress 2014 in Dubai. Designed to be integrated directly into any image viewer, such as a PACS, Advanced Visualization Viewer or Universal Viewer, Blackford Analysis’ products work within existing systems to enable instant comparison of multiple image studies.
The U.S. Food and Drug Administration (FDA) Medtronic Inc.’s Valiant Captivia Thoracic Stent Graft System to treat type B aortic dissections. Supported by the results of the U.S. Medtronic DISSECTION trial, the new indication provides physicians a minimally invasive alternative to open surgical repair and medical therapy.
radiation dose management, monitoring

Radiation dose continues to rise as the number of computed tomography (CT), nuclear, angiography and fluoroscopy examinations grow, leading to a greater risk of patient overexposure to radiation. Healthcare providers must reinforce their efforts to monitor and visualize dose levels from radiology examinations to enhance patient safety and meet new regulatory demands. There also is a need to justify and optimize the usage of radiation dose to find a balance between safer practice, image quality and lower dose — all for the benefit of the patient. Implementing tools for automatic and continuous follow up of radiation dose is at the forefront of meeting these challenges.

Instead of making a chest incision for open heart surgery, cardiovascular surgeons can now use a new vacuum-like tool to remove potentially deadly, large clots that lodge in patients’ hearts. 

A large-scale analysis assessing the real-world risk of venous thromboembolism (VTE) in chemotherapy patients shows a greater occurrence of VTE than identified in clinical trials. Risk progressively increases during the year following treatment initiation, according to the report.

DoseTrack

Physicians have used radiation in medicine for more than a century. The use of radiation in diagnostic imaging, including computed tomography (CT), fluoroscopy, angiography, mammography, computed radiography (CR) and digital radiography (DR), as well as in nuclear medicine, has aided greatly in the diagnosis and treatment of cancer and other diseases. 

Ekos Corp., a BTG International group company, published results of its Ultrasound Accelerated Thrombolysis of Pulmonary Embolism (PE) trial (ULTIMA) in the peer-reviewed journal of the American Heart Association, Circulation. The announcement was made at the International Symposium on Endovascular Therapy (ISET), Miami, Fla.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now